Evidence map›Paper›PMID 33913042›Full record

ReviewAAPS PharmSciTech2021

Borneol: a Promising Monoterpenoid in Enhancing Drug Delivery Across Various Physiological Barriers.

Madhur Kulkarni, Niserga Sawant, Anjali Kolapkar, Aishwarya Huprikar, Namita Desai

Abstract readReview
PubMed Publisher
In one paragraph

Review in AAPS PharmSciTech, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 1 pooled it
4.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 1 synthesis or guideline pooled it, 73 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. [Neuroprotective effects of idebenone combined with borneol via the dopamine signaling pathway in a transgenic zebrafish model of Parkinson's disease].Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi · 2025
    Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Complete Assignments ofMolecules (Basel, Switzerland) · 2025
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Madhur KulkarniDepartment of Pharmaceutics, SCES's Indira College of Pharmacy, New Pune Mumbai Highway, Tathawade, Pune, Maharashtra, 411033, India. madhur.kulkarni@indiraicp.edu.in.
Niserga SawantC. U. Shah College of Pharmacy, SNDT Women's University, Santacruz (W), Mumbai, Maharashtra, 400 049, India.
Anjali KolapkarDepartment of Pharmaceutics, SCES's Indira College of Pharmacy, New Pune Mumbai Highway, Tathawade, Pune, Maharashtra, 411033, India.
Aishwarya HuprikarDepartment of Pharmaceutics, SCES's Indira College of Pharmacy, New Pune Mumbai Highway, Tathawade, Pune, Maharashtra, 411033, India.
Namita DesaiC. U. Shah College of Pharmacy, SNDT Women's University, Santacruz (W), Mumbai, Maharashtra, 400 049, India.
Hindu College of Pharmacy · INShreemati Nathibai Damodar Thackersey Women's University · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Incorporation of permeation enhancers is one of the most widely employed approaches for delivering drugs across biological membranes. Permeation enhancers aid in delivering drugs across various physiological barriers such as brain capillary endothelium, stratum corneum, corneal epithelium, and mucosal membranes that pose resistance to the entry of a majority of drugs. Borneol is a natural, plant-derived, lipophilic, volatile, bicyclic monoterpenoid belonging to the class of camphene. It has been used under the names "Bing Pian" or "Long Nao" in Traditional Chinese Medicine for more than 1000 years. Borneol has been incorporated predominantly as an adjuvant in the traditional Chinese formulations of centrally acting drugs to improve drug delivery to the brain. This background knowledge and anecdotal evidence have led to extensive research in establishing borneol as a permeation enhancer across the blood-brain barrier. Alteration in cell membrane lipid structures and modulation of multiple ATP binding cassette transporters as well as tight junction proteins are the major contributing factors to blood-brain barrier opening functions of borneol. Owing to these mechanisms of altering membrane properties, borneol has also shown promising potential to improve drug delivery across other physiological barriers as well. The current review focuses on the role of borneol as a permeation enhancer across the blood-brain barrier, mucosal barriers including nasal and gastrointestinal linings, transdermal, transcorneal, and blood optic nerve barrier.

Indexed as

Drug Delivery SystemsAnimalsBlood-Brain BarrierCamphanesHumansMucous MembranePermeabilityCamphanesisoborneolBBBborneolmucosal deliverynatural permeation enhancertransdermal delivery

Identifiers

PMID33913042
OpenAlexW3159268917

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.